Clinical Trials Logo

Citation(s)

A Phase I-II Pharmacokinetic/Pharmacodynamic Study of Replagal to Assess the Effects of Alternative Dose and Regimen in Patients With Fabry Disease

Details for clinical trial NCT00075244